66 filings
8-K
IDYA
Ideaya Biosciences Inc
12 Mar 24
IDEAYA Announces Clinical Collaboration to Evaluate IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer
6:04am
8-K
IDYA
Ideaya Biosciences Inc
20 Feb 24
IDEAYA Biosciences, Inc. Reports Fourth Quarter and Full-Year 2023
6:07am
8-K
IDYA
Ideaya Biosciences Inc
23 Jan 24
Other Events
6:03am
8-K
IDYA
Ideaya Biosciences Inc
19 Jan 24
Entry into a Material Definitive Agreement
5:18pm
8-K
IDYA
Ideaya Biosciences Inc
16 Jan 24
Other Events
6:07am
8-K
2rjmc
12 Jan 24
Other Events
6:04am
8-K
a81oceno7itj4ghy0e
4 Dec 23
IDEAYA Announces Clinical Study Collaboration with Gilead Sciences to Evaluate Trodelvy® and IDE397 Combination in MTAP-Deletion Bladder Cancer
6:04am
8-K
m2uzhqain44
17 Nov 23
Entry into a Material Definitive Agreement
6:02am
8-K
4mogx9m9diboe
7 Nov 23
IDEAYA Biosciences, Inc. Reports Third Quarter 2023
6:01am
8-K
jo3bc2 82by1wt8d3
27 Oct 23
Other Events
4:23pm
8-K
l2icp20
24 Oct 23
Results of Operations and Financial Condition
4:21pm
8-K
nc1 8mf580
23 Oct 23
Other Events
8:09am
8-K
0lbp57t
26 Sep 23
Departure of Directors or Certain Officers
6:05am
8-K
vzzwabpxcm
10 Aug 23
IDEAYA Biosciences, Inc. Reports Second Quarter 2023
6:01am
8-K
zvryo4dqip1sm ekl6
3 Jul 23
Departure of Directors or Certain Officers
4:01pm
8-K
kgumhccr4k3wernz lz
30 Jun 23
Entry into a Material Definitive Agreement
4:01pm
8-K
p7d938wfov h3611ar0z
9 Jun 23
Submission of Matters to a Vote of Security Holders
4:06pm
8-K
2020s
6 Jun 23
Entry into a Material Definitive Agreement
6:02am
8-K
hh40o1zak8uw38er vkl
16 May 23
IDEAYA Expands Clinical Trial Collaboration and Supply Agreements with Pfizer
6:02am
8-K
r8fbea v4xd5c
9 May 23
IDEAYA Biosciences, Inc. Reports First Quarter 2023 Financial Results
6:01am